Apple Tree Partners

Sobre

Apple Tree Partners is a life-sciences company-creation and venture firm that starts companies from pre-IP ideas and asset spinouts, then invests from Seed through IPO and beyond. ATP frequently incubates and leads substantial financings, including Series A commitments above $30M. The firm reported $2.9B in total partnership capital commitments in 2025.

Sectores

• Ciencias de la vida

Inversiones destacadas

• Akero Therapeutics
• Chinook Therapeutics
• Stoke Therapeutics
• Aileron Therapeutics
• HeartWare International
• Corvidia Therapeutics
• Syntimmune
• VytronUS
• Tusker Medical
• SGX Pharmaceuticals

Inversores

• Seth L. HarrisonFounder and Managing Partner→
• Anna BatarinaPartner→
• Paul EisenbergChief Medical Officer and Venture Partner→
• Paul Da Silva JardineVenture Partner→
• Neena KadabaSenior Principal→
• Spiros LirasVenture Partner→
• Mark MitchnickVenture Partner→
• Joseph A. Yanchik IIIVenture Partner→

Cómo contactarlos

info@appletreepartners.com